Table 2 Comparison of results after the first and the second TACE therapy in the group of PLC and SLC.
From: Response comparison of PLC and SLC with magnetic resonance elastography after TACE
Parameter | PLC cycle 1 | PLC cycle 2 | p-value | SLC cycle 1 | SLC cycle 2 | p-value |
|---|---|---|---|---|---|---|
Total liver extent (cm2) | 166.0 ± 42.9 | 165.0 ± 50.7 | 0.02 | 130.0 ± 23.3 | 134.9 ± 28.0 | 0.05 |
Total liver elastography (kPa) | 3.6 ± 1.0 | 4.1 ± 1.1 | < 0.001 | 2.8 ± 0.7 | 2.8 ± 0.6 | < 0.0001 |
MAP T1 total liver (ms) | 686.2 ± 148.8 | 656.8 ± 53.5 | 0.001 | 654.0 ± 93.0 | 648.1 ± 93.1 | 0.6 |
MAP T2 total liver (ms) | 71.8 ± 13.0 | 76.3 ± 25.8 | 0.03 | 64.0 ± 7.0 | 63.8 ± 8.1 | 0.001 |
Left lobe extent (cm2) | 54.6 ± 13.8 | 52.9 ± 16.2 | 0.2 | 36.0 ± 10.6 | 34.6 ± 10.5 | 0.8 |
Left lobe elastography (kPa) | 3.2 ± 1.4 | 3.2 ± 1.3 | 0.006 | 2.8 ± 1.4 | 2.5 ± 0.6 | < 0.0001 |
MAP T1 left lobe (ms) | 679.4 ± 155.3 | 615.6 ± 64.0 | < 0.001 | 656.3 ± 130.1 | 660.9 ± 90.3 | 0.03 |
MAP T2 left lobe (ms) | 70.2 ± 16.6 | 70.8 ± 24.5 | 0.02 | 64.2 ± 10.0 | 63.2 ± 9.8 | 0.001 |
Right lobe extent (cm2) | 114.7 ± 36.9 | 107.0 ± 23.7 | 0.01 | 88.5 ± 17.4 | 92.2 ± 16.0 | 0.06 |
Right lobe elastography (kPa) | 3.3 ± 1.2 | 3.9 ± 1.5 | 0.02 | 2.8 ± 0.8 | 2.8 ± 0.7 | 0.01 |
MAP T1 right lobe (ms) | 686.2 ± 152.2 | 666.4 ± 56.3 | 0.03 | 639.2 ± 100.8 | 651.9 ± 90.4 | 0.2 |
MAP T2 right lobe (ms) | 73.7 ± 17.1 | 80.0 ± 27.9 | < 0.0001 | 63.1 ± 7.6 | 63.4 ± 9.0 | 0.006 |
Cancer extent (cm2) | 26.4 ± 27.2 | 21.2 ± 25.2 | 0.8 | 11.0 ± 8.7 | 5.5 ± 5.5 | < 0.0001 |
Cancer elastography (kPa) | 5.8 ± 1.2 | 6.9 ± 1.4 | 0.002 | 5.1 ± 1.4 | 5.4 ± 1.8 | 0.006 |
MAP T1 cancer (ms) | 776.0 ± 157.4 | 668.1 ± 92.2 | 0.3 | 773.4 ± 243.0 | 757.7 ± 201.5 | 0.02 |
MAP T2 cancer (ms) | 80.7 ± 26.1 | 94.2 ± 71.0 | < 0.0001 | 73.4 ± 15.9 | 65.8 ± 21.1 | 0.9 |
Reference elastography (kPa) | 2.1 ± 0.5 | 2.4 ± 0.6 | 0.2 | 1.8 ± 0.3 | 1.9 ± 0.4 | 0.006 |
